Microdeletions of 3q29 confer high risk for schizophrenia.

PubWeight™: 2.38‹?› | Rank: Top 2%

🔗 View Article (PMC 2917706)

Published in Am J Hum Genet on August 13, 2010

Authors

Jennifer Gladys Mulle1, Anne F Dodd, John A McGrath, Paula S Wolyniec, Adele A Mitchell, Amol C Shetty, Nara L Sobreira, David Valle, M Katharine Rudd, Glen Satten, David J Cutler, Ann E Pulver, Stephen T Warren

Author Affiliations

1: Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA. jmulle@emory.edu

Articles citing this

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91

Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry (2011) 4.29

Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature (2011) 3.51

High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron (2011) 3.08

Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry (2013) 3.01

Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70

Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry (2011) 2.28

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr Res (2015) 2.14

Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91

RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum Mol Genet (2012) 1.51

Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci (2012) 1.34

Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res (2011) 1.28

Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees. Biol Psychiatry (2011) 1.25

The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet (2012) 1.23

Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia. Cell Death Differ (2011) 1.21

Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med (2014) 1.17

Neurogenetics: advancing the "next-generation" of brain research. Neuron (2010) 1.16

CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet (2013) 1.14

Copy Number Variation detection from 1000 Genomes Project exon capture sequencing data. BMC Bioinformatics (2012) 1.09

Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psychiatry (2013) 1.09

Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry (2012) 1.08

Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. Appl Clin Genet (2012) 1.07

Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene. Mol Neurobiol (2011) 1.04

Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders. Eur J Hum Genet (2013) 1.03

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet (2016) 1.02

Abnormal kalirin signaling in neuropsychiatric disorders. Brain Res Bull (2013) 1.01

Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. Neuron (2015) 0.98

RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. BMC Genomics (2012) 0.97

Association testing of copy number variants in schizophrenia and autism spectrum disorders. J Neurodev Disord (2012) 0.96

Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics (2011) 0.95

High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy. BMC Med Genet (2011) 0.95

Multiplex ligation-dependant probe amplification study of children with idiopathic mental retardation in South India. Indian J Hum Genet (2013) 0.94

Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PLoS One (2015) 0.91

Copy number variants in German patients with schizophrenia. PLoS One (2013) 0.91

Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion. Am J Med Genet A (2013) 0.89

Copy number variants: a new molecular frontier in clinical psychiatry. Curr Psychiatry Rep (2011) 0.89

Genetic architecture of reciprocal CNVs. Curr Opin Genet Dev (2013) 0.88

Distribution of disease-associated copy number variants across distinct disorders of cognitive development. J Am Acad Child Adolesc Psychiatry (2013) 0.88

Population genetics identifies challenges in analyzing rare variants. Genet Epidemiol (2015) 0.87

Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. Behav Brain Funct (2012) 0.87

Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Hum Mol Genet (2014) 0.85

Dendritic spine alterations in schizophrenia. Neurosci Lett (2014) 0.84

Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Mol Genet Genomic Med (2013) 0.84

Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? Mol Autism (2013) 0.83

DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia. Transl Psychiatry (2017) 0.83

Ohnologs are overrepresented in pathogenic copy number mutations. Proc Natl Acad Sci U S A (2013) 0.82

Genomics of behavioral diseases. Front Genet (2012) 0.82

Reduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophrenia. Transl Psychiatry (2015) 0.82

Mosaic copy number variation in schizophrenia. Eur J Hum Genet (2013) 0.81

Robust regression analysis of copy number variation data based on a univariate score. PLoS One (2014) 0.81

Evaluating rare variants in complex disorders using next-generation sequencing. Curr Psychiatry Rep (2013) 0.80

Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. Schizophr Res (2011) 0.80

Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. Schizophr Bull (2012) 0.80

The 3q29 deletion confers >40-fold increase in risk for schizophrenia. Mol Psychiatry (2015) 0.79

A genome wide association study of mathematical ability reveals an association at chromosome 3q29, a locus associated with autism and learning difficulties: a preliminary study. PLoS One (2014) 0.79

Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls. Sci Rep (2014) 0.79

Kalirin signaling: implications for synaptic pathology. Mol Neurobiol (2011) 0.79

PAK1 protein expression in the auditory cortex of schizophrenia subjects. PLoS One (2013) 0.79

Microarray Analysis of Copy Number Variants on the Human Y Chromosome Reveals Novel and Frequent Duplications Overrepresented in Specific Haplogroups. PLoS One (2015) 0.79

Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition. Psychiatr Genet (2012) 0.78

Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies. PLoS One (2013) 0.78

The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration. Neural Dev (2016) 0.78

New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. Eur J Med Genet (2015) 0.77

Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia. Transl Psychiatry (2015) 0.77

Novel features of 3q29 deletion syndrome: Results from the 3q29 registry. Am J Med Genet A (2016) 0.76

Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defects. Genet Med (2014) 0.76

Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders. Sci Rep (2016) 0.75

Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders. J Neurosci Res (2016) 0.75

Opposing actions of the synapse-associated protein of 97-kDa molecular weight (SAP97) and Disrupted in Schizophrenia 1 (DISC1) on Wnt/β-catenin signaling. Neuroscience (2016) 0.75

Neurogenetic analysis of childhood disintegrative disorder. Mol Autism (2017) 0.75

Progress in genome-wide association studies of schizophrenia in Han Chinese populations. NPJ Schizophr (2017) 0.75

Potential Value of Genomic Copy Number Variations in Schizophrenia. Front Mol Neurosci (2017) 0.75

Articles cited by this

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68

Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature (2008) 20.31

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet (2008) 10.19

A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet (2008) 8.44

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics (2004) 8.29

Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12

Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79

Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13

Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nat Genet (2004) 5.78

A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01

Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87

Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03

Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci (2010) 2.90

Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry (2009) 2.82

Medicine. The future of psychiatric research: genomes and neural circuits. Science (2010) 2.79

Sparse representation and Bayesian detection of genome copy number alterations from microarray data. Bioinformatics (2008) 2.65

Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet (2008) 2.59

Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet (2010) 2.54

3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet (2005) 2.38

Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull (2009) 2.25

Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet (2009) 2.13

A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet (2008) 2.12

Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci U S A (2009) 1.95

European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med (2009) 1.59

Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet (2003) 1.40

The role of SAP97 in synaptic glutamate receptor dynamics. Proc Natl Acad Sci U S A (2010) 1.30

Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem (2002) 1.24

Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry (2002) 1.23

Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol Psychiatry (2002) 1.17

GluR1 controls dendrite growth through its binding partner, SAP97. J Neurosci (2008) 1.14

Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem (2009) 1.13

A case of 3q29 microdeletion with novel features and a review of cytogenetically visible terminal 3q deletions. Clin Dysmorphol (2006) 1.13

An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. J Neural Transm (Vienna) (2008) 0.95

Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses. J Neurochem (2009) 0.91

Phosphorylation of RhoGDI1 by p21-activated kinase 2 mediates basic fibroblast growth factor-stimulated neurite outgrowth in PC12 cells. Biochem Biophys Res Commun (2008) 0.88

Dissecting the many genetic faces of schizophrenia. Epidemiol Psichiatr Soc (2009) 0.86

Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-up. J Psychiatr Res (2004) 0.81

Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29. Eur Neuropsychopharmacol (2007) 0.80

Articles by these authors

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Finding the missing heritability of complex diseases. Nature (2009) 67.95

The human disease network. Proc Natl Acad Sci U S A (2007) 19.58

A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 18.98

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Prepublication data sharing. Nature (2009) 12.24

Microarray-based genomic selection for high-throughput resequencing. Nat Methods (2007) 9.62

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2002) 9.50

The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88

Haplotype inference in random population samples. Am J Hum Genet (2002) 8.07

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A (2002) 6.45

Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet (2008) 6.42

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26

Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nat Genet (2004) 5.78

Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30

A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet (2008) 5.28

A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature (2005) 4.92

Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89

Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci (2004) 4.69

Completing the map of human genetic variation. Nature (2007) 4.38

Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet (2010) 4.29

Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89

The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol (2008) 3.72

MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem (2007) 3.71

Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60

A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci (2002) 3.54

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med (2011) 3.51

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2008) 3.34

Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24

Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron (2007) 3.17

The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions. Am J Med Genet A (2012) 3.12

Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03

Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet (2011) 2.87

The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85

Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry (2007) 2.84

Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med (2010) 2.82

RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron (2003) 2.81

Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73

Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70

Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet (2003) 2.66

RNA and microRNAs in fragile X mental retardation. Nat Cell Biol (2004) 2.63

Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55

Age-associated DNA methylation in pediatric populations. Genome Res (2012) 2.53

Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet (2003) 2.51

Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res (2004) 2.47

Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet (2011) 2.46

Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41

Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol (2011) 2.39

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry (2010) 2.35

The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A (2004) 2.34

Recurrent DNA inversion rearrangements in the human genome. Proc Natl Acad Sci U S A (2007) 2.29

Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27

Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci U S A (2007) 2.27

DNA methylation regulates MicroRNA expression. Cancer Biol Ther (2007) 2.21

PhenoDB: a new web-based tool for the collection, storage, and analysis of phenotypic features. Hum Mutat (2013) 2.13

Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet (2009) 2.12

Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci U S A (2007) 2.10

Peroxisome biogenesis disorders. Annu Rev Genomics Hum Genet (2003) 2.09

Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet (2009) 2.07

Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol (2008) 2.04

FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci (2007) 2.02

The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol (2007) 1.98

Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol (2004) 1.95

Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94

A 360-kb interchromosomal duplication of the human HYDIN locus. Genomics (2006) 1.91

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci (2010) 1.89

Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum Mol Genet (2003) 1.87

S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem (2008) 1.87

Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet (2006) 1.84

Local RNA translation at the synapse and in disease. J Neurosci (2011) 1.83

Fragile X syndrome. Eur J Hum Genet (2008) 1.81

Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry (2006) 1.80

Human centromeric chromatin is a dynamic chromosomal domain that can spread over noncentromeric DNA. Proc Natl Acad Sci U S A (2006) 1.72

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci Transl Med (2012) 1.72

Discrepancies in dbSNP confirmation rates and allele frequency distributions from varying genotyping error rates and patterns. Bioinformatics (2004) 1.72

Transcription, translation and fragile X syndrome. Curr Opin Genet Dev (2006) 1.72

Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology (2006) 1.71

Haplotype and missing data inference in nuclear families. Genome Res (2004) 1.69

New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci (2003) 1.68

Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol (2003) 1.67

The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat (2011) 1.65

New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum Mutat (2015) 1.64

Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 1.64

Validation and extension of an empirical Bayes method for SNP calling on Affymetrix microarrays. Genome Biol (2008) 1.61

Microarray-based resequencing of multiple Bacillus anthracis isolates. Genome Biol (2004) 1.61

Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet (2002) 1.59

European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med (2009) 1.59

"Genes to society"--the logic and process of the new curriculum for the Johns Hopkins University School of Medicine. Acad Med (2010) 1.57

No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57

Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol (2007) 1.57

HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol (2011) 1.54